ARCHIVES

Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage

This article is from The Cancer Letter archive.

Vol. 24 No. 31 | August 7, 1998

Download PDF Visit The Full Archive

Related Articles

Hammer Gives $100,000 to Expand Rosenberg’s T-Cell Growth Factor Clinical Studies

March 1, 1985

FDA Approves Gleevec In 73 Days, A Speed Record.

May 18, 2001

NCI Begins PLCO Screening Trial

November 26, 1993

To Improve Clinical Trials Participation, Groups Plan An Awareness Campaign.

October 13, 2000

NCI Budget Chief John Hartinger Retires.

August 4, 2006

CPRIT Sets Funding Priorities For Rare and Pediatric Cancers

November 14, 2014